ITM2B Antikörper (N-Term)
Kurzübersicht für ITM2B Antikörper (N-Term) (ABIN113331)
Target
Alle ITM2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Affinity chromatography.
-
Immunogen
- Peptide coupled to carrier protein. Amino terminal sequence of BRI protein (ITM2B)
-
-
-
-
Applikationshinweise
-
Suitable for Western blot and not recommended for Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline, pH 7.2 with 0.09 % sodium azide as preservative.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 2-8 °C for one month or (following reconstitution in aliquots) at -20 °C for longer.
-
-
- ITM2B (Integral Membrane Protein 2B (ITM2B))
-
Andere Bezeichnung
- ITM2B
-
Hintergrund
- This antibody has been developed against the amino terminal sequence of BRI protein (ITM2B), a type-II single spanning transmembrane protein found in brain and other tissues. Mutation of the BRI gene with concomitant elongation of the carboxy terminus and its cleavage by the protease furin has been shown to lead to deposition of a protein fragment that may be involved in the pathogenesis of familial British dementia.Synonyms: BRI, BRI2, ITM2B, Integral membrane protein 2B, Transmembrane protein BRI
-
Gen-ID
- 9445
-
NCBI Accession
- NP_068839
-
UniProt
- Q9Y287
Target
-